|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01498 PURAPHARM
Nominal 
0.680 +0.040 (+6.250%) | 2023/12 - Final HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | 2019/12 HKD(K$) | |
| Net Cash from / (used in) Operating Activities | 79,608 | 88,505 | (14,520) | 119,854 | 131,200 |
| Net Cash from / (used in) Investing Activities | (18,203) | (31,245) | 6,005 | (92,110) | (91,461) |
| Net Cash from / (used in) Financing Activities | (122,390) | (35,594) | (13,872) | (3,613) | (79,246) |
| Increase / (Decrease) in Cash & Cash Equivalents | (60,985) | 21,666 | (22,387) | 24,131 | (39,507) |
| Cash & Cash Equivalents at beginning of period | 75,831 | 59,671 | 75,810 | 50,429 | 90,516 |
| Effect of Foreign Exchange Rate Changes | 5,280 | (5,506) | 6,248 | 1,250 | (580) |
| Others | 0 | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | 20,126 | 75,831 | 59,671 | 75,810 | 50,429 |
| Remarks: | Real time quote last updated: 25/11/2024 10:23 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders ($) | HKD -18,686,000 |
| %Change | -50.402% |
| EPS / (LPS) | HKD -0.047 |
| NBV Per Share ($) | HKD 0.330 |